RIBOMIC Enters License Agreement with AJU Pharma for RBM-007 in Age-related Macular Degeneration

TOKYO--(BUSINESS WIRE)--RIBOMIC has signed the license agreement with AJU PHARM CO., LTD., Korean pharmaceutical company for RBM-007 licensing agreement.

Full Story →